FDA Insider Trading Scheme Concludes With Guilty Plea
This article was originally published in The Pink Sheet Daily
Executive Summary
The first-ever prosecution of an agency employee will likely result in jail time for the chemist. For the agency, the result is a new electronic monitoring system.